Liquidia to Report First Quarter 2022 Financial Results on May 12, 2022
May 05 2022 - 8:00AM
Liquidia Corporation (NASDAQ: LQDA) announced today that it will
report its first quarter 2022 financial results on Thursday, May
12, 2022. The company will host a conference call and webcast at
8:30 a.m. Eastern Time to discuss financial results and provide a
corporate update.
The live call may be accessed by dialing 1-877-707-8711
(domestic) or 1-857-270-6219 (international) and entering the
conference code: 4798065. A webcast of the call will be available
and archived for 30 days on Liquidia’s website at
https://liquidia.com/index.php/investors/events-and-presentations.
About Liquidia CorporationLiquidia
Corporation is a biopharmaceutical company focused on the
development and commercialization of products in pulmonary
hypertension and other applications of its PRINT® Technology. The
company operates through its two wholly owned subsidiaries,
Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia
Technologies has developed YUTREPIA™ (treprostinil) inhalation
powder for the treatment of pulmonary arterial hypertension (PAH).
Liquidia PAH provides the commercialization for rare disease
pharmaceutical products, such as generic Treprostinil Injection.
For more information, please visit www.liquidia.com.
Contact Information for Media &
InvestorsJason AdairSenior Vice President, Corporate
Development and
Strategy919.328.4400jason.adair@liquidia.com
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2023 to Apr 2024